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Application of 3-Dimensional Computed
Tomographic Image Guidance to
WATCHMAN Implantation and Impact
on Early Operator Learning Curve
Single-Center Experience
Dee Dee Wang, MD,a Marvin Eng, MD,a Daniel Kupsky, MD,a Eric Myers, BFA,b Michael Forbes, BFA,b
Mehnaz Rahman, MD,a Mohammad Zaidan, MD,a Sachin Parikh, MD,a Janet Wyman, DNP,a Milan Pantelic, MD,c
Thomas Song, MD,c Jeff Nadig, MD,c Patrick Karabon, MS,a Adam Greenbaum, MD,a William O’Neill, MDa

ABSTRACT
OBJECTIVES The aim of this study was to examine the impact of 3-dimensional (3D) computed tomographic (CT)
guided procedural planning for left atrial appendage (LAA) occlusion on the early operator WATCHMAN learning curve.
BACKGROUND Traditional WATCHMAN implantation is dependent on 2-dimensional transesophageal echocardiographic (TEE) sizing and intraprocedural guidance.
METHODS LAA occlusion with the WATCHMAN device was performed in 53 patients. Pre-procedural case plans were
generated from CT studies with recommended device size, catheter selection, and C-arm angle for deployment.
RESULTS All 53 patients underwent successful LAA occlusion with the WATCHMAN. Three-dimensional CT LAA
maximal-width sizing was 2.7  2.2 mm and 2.3  3.0 mm larger than 2-dimensional and 3D TEE measurements,
respectively (p # 0.0001). By CT imaging, device selection was 100% accurate. There were 4 peri-WATCHMAN leaks
(<4.5 mm) secondary to accessory LAA pedunculations. By 2-dimensional TEE maximal-width measurements alone,
62.3% (33 of 53) would have required larger devices. Using 3D TEE maximal-width measurements, 52.8% of cases
(28 of 53) would have required larger devices. Three-dimensional TEE length would have inappropriately excluded
10 patients from WATCHMAN implantation. Compared with the average of 1.8 devices used per implantation attempt in
PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation)
(82% success rate), the present site averaged 1.245 devices per implantation attempt (100% success rate). There were
no intraprocedural screen failures and no major adverse cardiac events.
CONCLUSIONS Three-dimensional CT image case planning provides a comprehensive and customized patient-speciﬁc
LAA assessment that appears to be accurate and may possibly facilitate reducing the early WATCHMAN implantation
learning curve. (J Am Coll Cardiol Intv 2016;9:2329–40) © 2016 by the American College of Cardiology Foundation.

S

tandard procedural guidance and device selec-

trials, on average 1.8 devices were used per patient to

tion for the WATCHMAN left atrial appendage

achieve adequate device sealing, illuminating the

(LAA) closure device is based on 2-dimensional

accuracy limitations of 2D TEE imaging for character-

(2D) transesophageal echocardiographic (TEE) guid-

izing the LAA (2). Incentives for increased accuracy

ance (1). However, in the early WATCHMAN clinical

include reducing device exchanges and catheter and
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ABBREVIATIONS

contrast use, therefore minimizing the oppor-

to late ventricular systolic phase that corresponds

AND ACRONYMS

tunity for complications (1).

with maximal end-diastolic ﬁlling for the LAA. Raw

CT = computed tomographic
LAA = left atrial appendage
TEE = transesophageal
echocardiographic

3D = 3-dimensional
2D = 2-dimensional

Recent

device

development

for

LAA

CT Digital Imaging and Communications in Medicine

occlusion has led us to recognize the unique

data containing the aforementioned diastolic phase of

and varied morphology of the LAA (3).

the LAA are then exported to specialized computer-

This morphological complexity may be un-

aided design segmentation software (Mimics), with

derappreciated using 2D modalities, and

which the blood volume of the left atrium, LAA, aortic

3-dimensional (3D) characterization may pro-

annulus, and rims of the superior vena cava and

vide similar beneﬁts to device sizing and

inferior vena cava are manually segmented and

procedure planning as demonstrated in transcatheter

3D-printed by 2 industrial designers (M.F., E.M.).

heart valve therapy (4). Furthermore, planning of

The LAA oriﬁce was deﬁned as the plane connect-

spatial navigation through the left atrium requires a

ing the pulmonary vein ridge superiorly to the infe-

unique perspective likely best replicated by 3D

rior junction of the left atrium and the LAA at the

imaging.

level of the circumﬂex artery. The LAA landing zone
is deﬁned as the entryway into the main lobe of the

SEE PAGE 2341

LAA, where a potential LAA device could comfortably
In our study, we examined the differences of

and safely be seated within the conﬁnes of the body

computed tomographic (CT) versus 2D and 3D TEE

of the appendage. On multiplanar CT reconstruction,

sizing of the LAA and the impact of 3D CT guidance on

this is commonly demarcated using a double-oblique

WATCHMAN device implantation.

method by placing the crosshairs at the level of the
takeoff of the proximal left circumﬂex artery from the

METHODS

left anterior descending artery extending, and then

Between May 2015 and February 2016, 53 consecutive
patients underwent LAA WATCHMAN implantation at
Henry Ford Hospital by the Center for Structural
Heart Disease. All patients underwent pre-procedural
CT imaging of the LAA, followed by intraprocedural
echocardiographic

characterization

and

guidance

with 2D and 3D TEE imaging.

by rotating the coronal and sagittal crosshairs
sequentially to align their crosshairs to run parallel to
the course of the main lobe of the LAA (Table 1). If the
LAA ostium is ambiguous, a physical WATCHMAN
device is implanted ex vivo in the patient’s 3D-printed LAA to test-ﬁt the device to approximate the device landing zone (Table 1). Maximal and minimal
diameters and area of the LAA landing zone are

CT IMAGE ACQUISITION AND POST-PROCESSING

measured (Table 1). Device size is determined by the

SOFTWARE. Pre-procedural

a

widest diameter of the landing zone measured by CT

electrocardio-

imaging and selection according to the WATCHMAN

imaging

contrast-enhanced,

retrospectively

graphically

CT

gated

involved

angiographic

acquisition

instructions for use. Maximal length of the LAA was

without electrocardiographic dose modulation using

deﬁned as the linear distance from the center of the

a GE Discovery CT750 (GE Healthcare, Waukesha,

true ostium of the LAA landing zone to the distal

Wisconsin). Iodinated contrast, Isovue 370 (Bracco

terminus of the main lobe of the appendage (Figure 1).

Diagnostics, Patheon Italia, Ferentino, Italy) was

Once the WATCHMAN device size has been chosen,

injected at a rate of 4 ml/s, for a total volume of 80 ml,

the depth necessary for device deployment is known

through an 18-gauge peripheral intravenous line.

(equivalent to the width of the WATCHMAN device).

Tube current and voltage settings were adapted from

This length is drawn from the center of the landing

traditional CT angiographic gating protocols, adjusted

zone toward the main lobe of the distal tip of the LAA

for body mass index.

and then projected into inverted maximal-intensity

After image acquisition, CT Digital Imaging and

projections with the 3D crosshairs overlay showing

Communications in Medicine data were analyzed

both the landing zone and device surface as a single

using Vitrea (Vital Images, Minnetonka, Minnesota)

2D plane (Figure 2). This inverted maximal-intensity

and Mimics (Materialise, Leuven, Belgium). All pre-

projection is applied to simulate the LAA intra-

procedural

computer-aided

procedural angiogram, to anticipate the necessary

design analysis, and 3D printing were performed on

C-arm angles, depth of deployment, and catheter tip

site at Henry Ford Health System in partnership with

positioning for maximal device implant coaxiality to

the Henry Ford Innovation Institute.

the LAA.

imaging,

planning,

Using a 5% to 95% reconstructed valve cine series

INTRA-PROCEDURAL TEE GUIDANCE. Intraprocedural

of the CT study, the LAA is analyzed in 10% recon-

TEE

structed R-R intervals to enable selection of the mid

CX50 echocardiograph and an X7-2T TEE probe

imaging

was

performed

using
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(Philips Medical Systems, Andover, Massachusetts).

correlation coefﬁcient of 0.86 and a Pearson correla-

Three-dimensional and 3D TEE measurements were

tion coefﬁcient <0.001 (Figure 5). In analyzing the

performed after an LAA mean pressure >10 mm Hg.

maximal length of the LAA from identiﬁed device

Baseline measurements of the LAA landing zone

landing zone to the tip of the main lobe of the

diameter and depth were recorded at 0 , 45  , 90 , and

appendage, CT sizing of the maximal length was

135  . Three-dimensional TEE measurements were

larger than both 2D and 3D TEE sizing (p # 0.0001).

performed intraprocedurally on the CX50 using the

The mean difference of 3D CT and 2D TEE maximal

3D TEE software QLAB version 9.0 (Philips Medical

LAA length measurements was 4.0  5.8 mm, with an

Systems). With the aid of the 3D printout, meticulous

intraclass correlation coefﬁcient of 0.97 and a Pearson

care was taken to ensure that similar landing zones

correlation coefﬁcient <0.001 (Figure 6).
By 2D TEE maximal width, 62.3% of the patients

were obtained on 2D and 3D TEE imaging compared
with CT imaging for device sizing. Computer-

(33

generated deployment sheath simulations were then

device and required upsizing to a larger device size

of

53)

would

have

received

the

incorrect

modeled from the CT volumetric dataset in the 2D

intraprocedurally. By 3D TEE maximal width, 52.8%

TEE 45  and 2D TEE 135  views to project the landing

of the patients (28 of 53) would have been under-

zone appearance on TEE imaging and for maximal

sized and required upsizing to a larger device

device and catheter coaxiality positioning to the main

intraprocedurally.

lobe of the LAA (Figure 3).

CLINICAL IMPACT. All 53 patients underwent suc-

STATISTICAL ANALYSIS. Paired t-test and analysis

of variance were used to evaluate for statistical signiﬁcance between 2D and 3D TEE and CT measurements. Degree of correlation was calculated using the
Pearson correlation coefﬁcient (r value) in SAS
version 9.4 (SAS Institute, Cary, North Carolina).
Statistical signiﬁcance was deﬁned as p < 0.05. The
Bland-Altman method was used to describe the mean
difference between 2 modalities. For comparison of
major adverse events, patient procedural outcome
data from the PROTECT AF (WATCHMAN Left Atrial
Appendage System for Embolic Protection in Patients
With Atrial Fibrillation), CAP (Continued Access to
PROTECT AF), PREVAIL (WATCHMAN LAA Closure
Device in Patients With Atrial Fibrillation Versus Long
Term Warfarin Therapy), and CAP2 (Continued Access
to PREVAIL) trials were collected and analyzed
against data from our study using 2-sample z tests for
proportions.

cessful device implantation. There were no screen
failures.

If

traditional

2D

TEE

maximal-width

dimensions had been applied to this study population, 3 patients would have been excluded from LAA
occlusion

intraprocedurally

because

of

2D

TEE

undersizing. If 3D TEE maximal width had been
applied to this study population, 3 patients would
have been excluded from LAA occlusion, the ﬁrst 2
because of 3D TEE undersizing of the LAA and the
latter because of misidentiﬁcation of the LAA landing
zone and oversizing of the LAA into the left atrium,
exceeding available device sizes. By maximal length
of

LAA measurements, intraprocedural 2D

TEE

maximal length would have screen-failed 18.9% of
the patients (10 of 53) from WATCHMAN candidacy.
Of these 53 patients, there were 4 peri-WATCHMAN
leaks, each <4.5 mm in width. Two of the 4 periWATCHMAN leaks were anticipated because of the
presence of LAA trabeculations; the remaining 2 were
secondary to device positioning.

RESULTS

PROCEDURE-RELATED SAFETY EVENTS: ELIMINATION

From May 2015 through February 2016, 53 consecutive patients underwent successful WATCHMAN
implantation (Table 2).

OF EARLY IMPLANTER LEARNING CURVE. Compared

with PROTECT AF, CAP, PREVAIL, and CAP2 major
adverse cardiac events, all of our patients underwent
successful device implantation (Table 3) (1,5). Total

DEVICE SIZING. Compared with 2D and 3D TEE

procedure time in the ﬁrst 3 patients at our new

sizing, 3D CT maximal width of the LAA landing zone

implanting site was 48  11 min, 34 min faster than

was larger (p # 0.0001). The mean difference between

the ﬁrst 3 patients at each new implanting site in the

3D CT maximal LAA width and 2D TEE measurements

ﬁrst half of the PROTECT AF trial and 7 min faster

was 2.7  2.2 mm, with an intraclass correlation

compared with the rest of the PROTECT AF study

coefﬁcient

(Table 4) (2,5).

of

0.77

and

a

Pearson

correlation

coefﬁcient <0.001 (Figure 4). The mean difference

In all 53 cases, only 1 device size was used for

between 3D CT maximal LAA width and 3D TEE

each case. Compared with the ﬁrst half of PROTECT

measurements was 2.3  3.0 mm, with an intraclass

AF, in which an average of 1.8 devices were used
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T A B L E 1 CT Based Left Atrial Appendage Case Plan Protocol

Steps

In-Depth Description

Sizing the LAA
landing zone

Example Images

Load the 0%–95% valve series of the LAA into CT viewer. Identify the phase
that corresponds to mid to end LV systolic ﬁlling that corresponds best to
maximal LAA end-diastolic ﬁlling. In the coronal cross sections, place the
crosshairs on the LAA.

In a curved multiplanar reformat plane, within the coronal window, doubleoblique the sagittal crosshairs (blue) to the direction of the main lobe of
the LAA.

In the sagittal window, within a curved multiplanar reformat plane, advance
the crosshairs to the level of the proximal LCx artery takeoff from the LAD.
Then, double-oblique the coronal crosshairs (green) to the direction of the
main lobe of the LAA (commonly runs parallel to the course of the LAD).

On the axial cross sections, measure the maximal and minimal diameters, area,
and circumference of the LAA landing zone.

Identifying the
maximal length
of the LAA
landing zone to
distal tip of the
main lobe
of the LAA

Identify the maximal length or depth of the LAA from the landing zone to the
distal LAA tip of in the sagittal and coronal views, and record the largest
value. (Scroll in and out of the identiﬁed view to ensure maximal length is
accounted for.)

Generating the
length of the
WATCHMAN
delivery sheath

Adjust the length measurement to equal the maximal width of the
WATCHMAN device selected (per the sizing guidelines from the
WATCHMAN DFU). In this patient, a 24.7-mm maximal-width diameter
corresponds to selection of a 27-mm WATCHMAN device, and hence
delivery sheath depth of w27 mm (0.5 mm to account for distal delivery
tip plastic tricut length and presence or absence of LAA pedunculations
protruding into site of catheter positioning).

C-arm angles

Segment the LAA, left atrium, into a transparent 3D volume image. In the 3D
window, align the axial (red) and sagittal (blue) planes to intersect
perpendicular to each other. Show the delivery sheath length in the 3D
image (pink line).

Continued on the next page

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on March 22, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

Wang et al.

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 9, NO. 22, 2016
NOVEMBER 28, 2016:2329–40

2333

CT Image Guidance for WATCHMAN Implantation

T A B L E 1 Continued

Steps

In-Depth Description

Example Images

Implanter case
plan

Apply inverted MIP to the 3D volume to project the 3D image in a black-andwhite radiographic simulation. Load the image screenshot into Microsoft
PowerPoint, apply “insert art tool,” and overlay the crosshairs with a
bracket and line (over the demarcated delivery sheath) to simulate the
WATCHMAN device landing zone and delivery sheath depth positioning.

Interventional
imaging case
plan (TEE 45
view)

Segment the aortic annulus, proximal LAD and LCx into the 3D volume. Adjust
the image to bring the aortic valve centered and anterior. Adjust the axial
(red) and coronal (green) crosshairs to intersect perpendicular to each
other. The yellow arrow depicts delivery sheath positioning when imaging
in the 2D TEE midesophageal short-axis view of the aortic valve.

TEE 135 view

Rotate the 3D image along the sagittal plane (red crosshairs) until the aorta is
at 3 o’clock and anterior to the LAA. Remove the aortic root from the 3D
volume. With the LAA pointing towards 6 o’clock, the yellow arrow
depicts the delivery catheter and sheath tip position for maximal catheter
coaxiality to optimize WATCHMAN implantation. The sagittal plane (red
crosshairs) now depicts the landing zone to be shown by 2D TEE in the
135 view.

3D printout
assisted type of
delivery
catheter
(single,
anterior,
double curve)
selection

3D printouts of patient’s speciﬁc left atrial, LAA anatomy were generated to
assist in bench-test selection of catheter curvature for device
implantation.

CT ¼ computed tomographic; DFU ¼ directions for use; LA ¼ left atrium; LAA ¼ left atrial appendage; LAD ¼ left anterior descending coronary artery; LC ¼ left circumﬂex coronary artery; LCx ¼ left
circumﬂex coronary artery; LV ¼ left ventricular; MIP ¼ maximal¼intensity projection; TEE ¼ transesophageal echocardiographic; 3D ¼ 3-dimensional; 2D ¼ 2-dimensional.

per implantation attempt with an 82% implantation

accounting for more than 1 device used on average.

success rate, our site averaged 1.245 devices per

In 6 of these 7 patients, more than 1 device was

implantation attempt with a 100% implantation

used because of difﬁcult transseptal crossing and

success

difﬁculty in obtaining catheter device coaxiality for

rate.

Of

53

patients,

7

were

outliers,
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F I G U R E 1 Deﬁning the Left Atrial Appendage Landing Zone

Continued on the next page
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F I G U R E 2 Computed Tomographic Case Plan for Intraprocedural Left Atrial Appendage C-Arm Fluoroscopic Imaging

After sizing and depth analysis are completed for the left atrial appendage (LAA) landing zone, the LAA, left atrium, and any pertinent adjacent
anatomic landmark structures (transcatheter valves, sternotomy wires, circumﬂex artery coronary stents, etc.) are segmented and projected
into inverted maximal intensity projection to simulate the intraprocedural LAA angiogram (A). Appropriate C-arm angles are generated and
demonstrated on the actual day of a successful procedural implantation with baseline LAA angiography at those angles and ﬁnal device
implantation corresponding to the mockup case plan provided by computed tomography (B,C).

F I G U R E 1 Continued

The mid to end left ventricular systolic phase corresponding to maximal left atrial appendage (LAA) diastolic ﬁlling is identiﬁed and segmented
into a computer-aided design 3-dimensional (3D) volume image of the patient’s speciﬁc anatomy (A). Traditional sizing of the LAA typically
occurs at the junction between the left atrium (LA) and LAA interface. However, this is the incorrect landing zone for most WATCHMAN
implantations (B). Sizing the device to the junction of the LA and the LAA and then virtually implanting that sized device in the patient’s speciﬁc
heart demonstrates that the device would cause perforation of the LAA, as there is insufﬁcient depth to implant the device, thereby causing
the WATCHMAN ﬁxation anchors to puncture the LAA because of the patient’s speciﬁc LAA angulation. The concept of using a letter “T”
(with equal width and length) to simulate the WATCHMAN device without physically implanting the actual model illustrates the same concerns
(C). Once the main lobe of the LAA is identiﬁed, and the WATCHMAN device positioning is adjusted to be parallel to the blood ﬂow of the main
lobe of the LAA, computer-aided design modeling demonstrates that there is sufﬁcient depth and supporting circumferential LAA tubular
scaffolding to implant the WATCHMAN device at the corrected landing zone. Again, the concept of the letter “T” demonstrates that there is
equal width and depth to ensure that: 1) all WATCHMAN ﬁxation anchors are covered within the lumen of and in contact with the inner surface
of the LAA; 2) there is a sufﬁcient seal around the cap of the device; and 3) major outpouchings or pedunculations are covered inferior to
the device landing zone (D).
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F I G U R E 3 Computed Tomographic Case Plan for Intraprocedural Left Atrial Appendage Transesophageal Echocardiographic

Imaging Guidance

The 2 most important views for WATCHMAN implantation, the 2-dimensional (2D) transesophageal echocardiographic (TEE) 45 and 135 views,
are segmented by computed tomography. The previously identiﬁed necessary depth of deployment for the device size chosen is projected with a
3-dimensional (3D) straight line into the 3D transparent volume image of the LAA to demonstrate catheter positioning (A,B) as it would appear
on the corresponding intraprocedural 2D TEE 45 and 135 views (C,D). In complex anatomies, this helps identify if the correct delivery sheath
catheter tip is being selected to obtain the distal portion catheter tip coaxiality necessary as deﬁned by the 3D computed tomographic volumetric dataset. Additionally, the computed tomography–generated delivery catheter positioning on 2D TEE imaging helps guide intraprocedural
device and catheter positioning to minimize device pop-out and peri-WATCHMAN leak (the latter secondary to canted device delivery).

deployment. The seventh patient had 3 devices of

There

were

no

major

cardiovascular

events,

the same size used secondary to difﬁculty achieving

speciﬁcally no pericardial effusions, cardiac ruptures,

device deployment at the necessary landing zone

or device embolizations or migrations. There was

depth because of the presence of prominent intra-

1

LAA trabeculations.

observed on 1-month post-implantation CT follow-up.

thrombus

formation

post–device
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T A B L E 2 Patient Baseline and Procedural Characteristics

F I G U R E 4 Mean Difference Between 3-Dimensional Computed Tomographic and 2-

(n ¼ 53)

Dimensional Transesophageal Echocardiographic Maximal Left Atrial Appendage

77.5  7.7

Age, yrs
Men

31

Heart failure

28

Hypertension

48

Diabetes mellitus

22

Prior stroke or TIA

22

Coronary heart disease

36

Chronic renal failure

21

Prior major bleed*

32

Prior transfusion

Width

16
3.2  1.2

CHADS2 score
CHA2DS2-VASc score

5.3  1.4

HAS-BLED score

3.6  1.3

LA mean pressure, mm Hg

15.830  4.999

Values are mean  SD or n. *Deﬁned as any bleeding requiring hospitalization or
causing a decrease in hemoglobin level >2 g/dl, and/or requiring blood transfusion
of $2 U of blood, and/or intracranial bleed (12).

DISCUSSION
data using modern scanners found the maximal LAA
Our study demonstrates the added value of 3D CT
guided case planning in simplifying the WATCHMAN
implantation process, providing a high level of
device selection accuracy and spatial planning to

width to be 25.8  4.7 mm on CT imaging versus 25.1
 4.4 mm on TEE imaging (p ¼ 0.016), corroborating
our own ﬁndings (8).
In our analysis, although the measurements from

simply guide catheter selection. We found CT

CT imaging and the gold standard of 2D TEE imaging

screening for the maximal width of the LAA to be

had reasonable agreement, analysis with the calcu-

100% accurate, and the extra WATCHMAN devices

lation of the Pearson correlation coefﬁcient showed

used were as a result of full device recapture for

that there was a difference when sizing by CT versus

inaccurate deployment. Additionally, the combina-

TEE measurement for the LAA (Pearson correlation

tion of correct device selection, 3D print modeling,

coefﬁcient <0.001). This difference was signiﬁcant

and CT spatial planning for guide catheter selection was able provide early implantation efﬁciency
(48  11 min). Whether or not planning and

F I G U R E 5 Mean Difference Between 3-Dimensional Computed Tomographic and 3-

simpliﬁcation of the procedure improved safety is

Dimensional Transesophageal Echocardiographic Maximal Left Atrial Appendage

speculative; in theory, reduction of device and

Width

catheter exchanges would eliminate opportunities
for complications such as cardiac perforation and
air and possibly device embolization. Given the
widely available technology of cardiac CT, planning
to this level of detail may further increase safety
for the implantation of not only the WATCHMAN
but the growing array of devices available for the
LAA.
Our data reinforce the advantages of using a highresolution volumetric dataset to characterize the
LAA. Post-implantation CT imaging showed greater
appreciation for leaks relative to TEE imaging, highlighting possible blind spots in TEE interrogation of
the LAA (6). The ﬁrst use of CT imaging to deﬁne the
LAA involved a 16-slice scanner and found that the
segmented CT images yielded larger measurements
than both planar and TEE measurements (7). Recent
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the ﬁrst to demonstrate that despite adequate intra-

F I G U R E 6 Mean Difference Between 3-Dimensional Computed Tomographic and 2-

procedural LAA loading conditions (LA mean pressure

Dimensional Transesophageal Echocardiographic Maximal Left Atrial Appendage

>10 mm Hg), 2D and 3D TEE imaging still undersizes

Length

the LAA compared with CT imaging.
Beyond volume loading, LAA contractility affects
sizing (8,10). A gated CT scan’s high spatial resolution
allows visualization of LAA motion during the cardiac
cycle and obtaining maximal LAA dimensions in left
ventricular end-systole and minimal dimensions in
left ventricular end-diastole. This is not readily
appreciated on 2D TEE imaging, because of poor
spatial resolution.
Successful implantation of the WATCHMAN device
depends on accurate sizing of the LAA landing zone
and positioning of the catheter at the correct depth
for device unsheathing (1,11). The length characterization by CT imaging differed signiﬁcantly from that
by 2D TEE imaging (mean difference 4.0  5.8 mm),
illustrating

a

signiﬁcant

liability

of

2D

TEE

imaging for case planning. Because the relative
depth-to-width ratios are critical in understanding
WATCHMAN implantation feasibility and success,
enough between these 2 imaging modalities to

given the unpredictability of LAA morphology, a

directly

comprehensive imaging modality with high spatial

affect

device

size

selection

for

LAA

WATCHMAN implantation. The intraclass correlation

resolution is vital.

coefﬁcient was high, as we were comparing 2 imaging

Given the questionable accuracy of TEE imaging,

methods; however, CT imaging showed larger sizes

we maintain that high-resolution volumetric imag-

than 2D and 3D TEE imaging. A high correlation is

ing with CT should be the preferred method to

usually expected when comparing similar but slightly

mitigate improper sizing that could lead to peri-

different imaging modalities. Hence, a high correla-

WATCHMAN leak, device embolization, and poten-

tion does not imply good agreement.

tially

other

major

adverse

catastrophic

events.

By noninvasive laboratory practices, patients are

Notably, applying the WATCHMAN U.S. Food and

volume-depleted for outpatient TEE studies, as they

Drug Administration–approved directions for use to

must fast for 6 h prior to a TEE procedure and 12 h

CT sizing for use is safe, as there were no pericar-

before a cardiac catheterization procedure. LAA size

dial effusions post-implantation or device emboli-

is heavily dependent on adequate pre-load, and

zations. Incorporation of a comprehensive 3D CT

hence pre-procedural outpatient TEE imaging greatly

case plan analysis not only leads to fewer devices

undersizes the true LAA dimensions (9). Our study is

used per implantation procedure but may improve

T A B L E 3 Clinical Impact of 3-Dimensional Computed Tomographic Procedural Case Planning in Eliminating Early WATCHMAN Operator

Learning Curve

Pericardial effusion with cardiac tamponade

PROTECT AF
(n ¼ 463)

CAP
(n ¼ 566)

PREVAIL
(n ¼ 269)

CAP2
(n ¼ 579)

Study Site Integrating
CT LAA Case Plan
(n ¼ 53)

13 (2.8)

7 (1.2)

4 (1.5)

8 (1.2)

0 (0.0)

Device embolization

3 (0.6)

1 (0.2)

2 (0.7)

0 (0.0)

0 (0.0)

Pericardial effusion, no intervention

4 (0.9)

5 (0.9)

0 (0.0)

3 (0.5)

0 (0.0)

Cardiac perforation (surgical repair)

7 (1.5)

1 (0.2)

1 (0.4)

3 (0.5)

0 (0.0)

Device migration

1 (0.2)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Device thrombus

2 (0.4)

1 (0.2)

1 (0.4)

5 (0.9)

1 (2.4)

Values are n (%).
CAP ¼ Continued Access to PROTECT AF; CAP2 ¼ Continued Access to PREVAIL; CT ¼ computed tomographic; LAA ¼ left atrial appendage; PREVAIL ¼ WATCHMAN LAA
Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy; PROTECT AF ¼ WATCHMAN Left Atrial Appendage System for Embolic Protection in
Patients With Atrial Fibrillation.
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T A B L E 4 Single-Center New Implanter WATCHMAN Procedure Major Adverse Cardiac Outcomes Compared With WATCHMAN Clinical Trials

PROTECT AF
First Half
of Trial

PROTECT AF

Second Half
of Trial

First 3
Patients

Other
Patients

Implantation success,
n/total (%)

239/271 (82%)

Procedure/device-related
safety adverse event
within 7 days

27/271 (10.0%)

15/271 (5.5%)

19/154 (12.3%)

Serious pericardial
effusion within 7 days

17/271 (6.3%)

10/271 (3.7%)

67  36

58  33

Procedure time,
mean  SD, min

246/271 (90.8%) 133/154 (86.4%) 352/388 (90.7%)

CSHD 3D CT
Guided New
Implanting Site

p Value (vs. First Half of
PROTECT AF Trial)

53/53 (100%)

0.005

23/288 (5.8%)

0/53 (0.0%)

0.01

10/154 (6.5%)

17/388 (4.4%)

0/53 (0.0%)

0.03

82  40

55  29

48  11 (mean time for
ﬁrst 3 patients)

0.23 (ﬁrst 3 patients,
head-to-head comparison)

CSHD ¼ Center for Structural Heart Disease, Henry Ford Health System; other abbreviations as in Table 3.

the safety and reduce the challenges seen in the

size of the landing zone, angulation of the LAA main

early learning experience of WATCHMAN implanta-

lobe, and location of trabeculations and pectinate

tions. It should be noted that a 16.3% rate of serious

muscle is necessary for successful device implanta-

pericardial effusions and procedure- or device-

tion. Our study is distinguished by reporting not only

related safety adverse events were attributed to

the differences in imaging modalities but the impact

the early operator learning curve witnessed in the

of their implementation on clinical success. Compre-

PROTECT

hensive CT case planning is not only feasible but may

AF

study

(5).

Three-dimensional

CT

guided case planning for the LAA is not only more

enhance procedural safety and efﬁciency, analogous

accurate but provides faster, safer, and personalized

to the impact delivered in transcatheter aortic valve

care to patients than allowed by ﬂuoroscopy or TEE

interventions.

imaging alone.
STUDY
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With our CT case planning, each patient had
a 3D printout generated that included the left atrium

PERSPECTIVES

and LAA anatomy. The early CT case planning was
adapted from bench modeling testing of WATCHMAN
devices in the 3D printout and then applied to the CT
post-processing to understand the deﬁnition of the
LAA landing zone and positioning necessary for successful WATCHMAN implantation. The incremental
value of 3D printing added to the LAA device case

WHAT IS KNOWN? Two-dimensional TEE imaging is currently
the gold standard and recommended imaging modality for LAA
occlusion with the WATCHMAN device.
WHAT IS NEW? Application of 3D CT imaging allows
a comprehensive analysis of LAA anatomy and more appropriate

planning served as a safety net in procedural plan-

device size selection and requires fewer devices per case.

ning awareness that is difﬁcult to quantify.

Application of 3D CT image guidance in new implanting sites may
reduce the duration of procedures and reduce complications.

CONCLUSIONS
Accurate sizing and deployment of the WATCHMAN
device is achievable in a safe and precise environment with the incorporation of advanced 3D CT case

WHAT IS NEXT? Prospective randomized clinical trials are
necessary to prove that computed tomography is responsible for
improved procedural and safety outcomes compared with traditional imaging modalities.

planning. Detailed understanding and analysis of the
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